1. Appropriate indication
2. Properly obtained informed consent
3. Use of recommended post-polypectomy and post-cancer resection surveillance intervals
4. Use of recommended ulcerative colitis/Crohn’s disease surveillance intervals
5. Documentation of quality of the preparation
6. Cecal intubation rates
7. Detection of adenomas in asymptomatic patients
8. Withdrawal time
9. Biopsy specimens obtained in patients with chronic diarrhea
10. Number and distribution of biopsy samples in ulcerative colitis and Crohn’s disease patients
11. Mucosally-based peduncluated polyps and sessile polyps: documentation of resection or inability to resect
12. Measure of incidence of perforation by procedure type
13. Measure of incidence of postpolypectomy bleeding
14. Non-operative management of postpolypectomy bleeding
More Articles on Gastroenterology:
9 Things to Know About C. difficile Infection Diagnosis
10 Most-Read Stories on Gastroenterology
8 Top Topics From 2013 American Association for the Study of Liver Diseases Meeting
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
